Mitchell P. Kopin 13D and 13G filings for Aptevo Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-06-25 4:38 pm Unchanged | 2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing |
| 2025-04-25 4:07 pm Unchanged | 2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing |
| 2025-04-09 5:31 pm Unchanged | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing |